Axillary Downstaging in Occult Primary Breast Cancer After Neoadjuvant Chemotherapy

被引：0
|
作者：
Van den Bruele, A. Botty [1 ]
Pilewskie, M. [1 ]
Lavery, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P60
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [41] Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
    Kuerer, HM
    Newman, LA
    Fornage, BD
    Dhingra, K
    Hunt, KK
    Buzdar, AU
    Ames, FC
    Ross, MI
    Feig, BW
    Hortobagyi, GN
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (08) : 673 - 680
  • [42] Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer
    Henry M. Kuerer
    Lisa A. Newman
    Bruno D. Fornage
    Kapil Dhingra
    Kelly K. Hunt
    Aman U. Buzdar
    Fred C. Ames
    Merrick I. Ross
    Barry W. Feig
    Gabriel N. Hortobagyi
    S. Eva Singletary
    Annals of Surgical Oncology, 1998, 5 : 673 - 680
  • [43] Omitting axillary surgery in breast cancer treated with neoadjuvant chemotherapy
    Jung, Ji-Jung
    Han, Wonshik
    GLAND SURGERY, 2024, 13 (09) : 1670 - 1672
  • [44] Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?
    Vugts, Guusje
    Nieuwenhuijzen, Grard A. P.
    Maaskant-Braat, Adriana J. G.
    Schipper, Robert J.
    Smidt, Marjolein L.
    ANNALS OF SURGERY, 2016, 263 (02) : E28 - E29
  • [45] HISTOLOGICAL REGRESSION OF BREAST-CANCER AFTER PRIMARY (NEOADJUVANT) CHEMOTHERAPY
    SINN, HP
    SCHMID, H
    JUNKERMANN, H
    HUOBER, J
    LEPPIEN, G
    KAUFMANN, M
    BASTERT, G
    OTTO, HF
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1994, 54 (10) : 552 - 558
  • [46] Treatment effect in the breast and axillary lymph nodes predicts low axillary disease burden after neoadjuvant chemotherapy for breast cancer
    Hieken, T. J.
    Shah, S. S.
    Degnim, A. C.
    Jakub, J. W.
    Boughey, J. C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S132 - S132
  • [47] Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases - a transSENTINA Analysis
    Kolberg, Hans-Christian
    Kuhn, Thorsten
    Krajewska, Maja
    Bauerfeind, Ingo
    Fehm, Tanja N.
    Fleige, Barbara
    Helms, Gisela
    Lebeau, Annette
    Stabler, Annette
    Schmatloch, Sabine
    Hausschild, Maik
    Schwentner, Lukas
    Schrenk, Peter
    Loibl, Sibylle
    Untch, Michael
    Kolberg-Liedtke, Cornelia
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (12) : 1229 - 1236
  • [48] Axillary management in breast cancer after neoadjuvant chemotherapy in the modern era: A national cancer database analysis
    Whitrock, Jenna N.
    Carter, Michela M.
    Leonard, Laura D.
    Lewis, Jaime D.
    Shaughnessy, Elizabeth A.
    Heelan, Alicia A.
    SURGERY, 2024, 175 (03) : 687 - 694
  • [49] Neoadjuvant chemotherapy for primary operable breast cancer
    Halberg, Anne Krag
    Gravesen, Charlotte Dahl
    Cold, Soren
    Jensen, Jeanette Dupont
    DANISH MEDICAL JOURNAL, 2020, 67 (12):
  • [50] Validity and Safety of Omission of Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy for Node-Positive Primary Breast Cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Jinno, Hiromitsu
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E82 - E83
12345